CCM
NKTR icon

Century Capital Management’s Nektar Therapeutics NKTR Stock Holding History

Century Capital Management’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$405K Buy
+1,379
New +$399K 0.07% 207

Other funds holding NKTR

O
OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Century Capital Management's NKTR Position: Q2 2017 in Review

Century Capital Management opened a new position in Nektar Therapeutics (NKTR) in Q2 2017: 1,379 shares worth $405K. The stake represents 0.07% of the portfolio and ranks #207 among its holdings.

197 funds tracked by Wall St. Rank hold NKTR as of Q2 2017.

  • Century Capital Management held 1,379 shares of Nektar Therapeutics worth $405K as of Q2 2017.
  • Nektar Therapeutics was a new Century Capital Management position in Q2 2017.
  • Nektar Therapeutics made up 0.07% of Century Capital Management's portfolio in Q2 2017, its #207 holding.
  • 197 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2017.

Based on Century Capital Management's 13F filing for Q2 2017, filed 10 Aug 2017.